We are live on
!
Find out more
OCM
Osterweis Capital Management Portfolio holdings
AUM
$2.12B
1-Year Est. Return
32.36%
This Fund
S&P 500
This Quarter
Est. Return
+7.71%
1 Year Est. Return
+32.36%
3 Year Est. Return
+93.72%
5 Year Est. Return
+113.14%
10 Year Est. Return
+557.09%
AUM
$1.57B
AUM Growth
+$20.2M
(+1.3%)
Cap. Flow
-$234M
Cap. Flow
% of AUM
-14.93%
Top 10 Holdings %
Top 10 Hldgs %
28.16%
Holding
125
New
20
Increased
41
Reduced
30
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$19.1M |
| 2 |
3M
MMM
|
+$11.4M |
| 3 |
Synopsys
SNPS
|
+$10.1M |
| 4 |
UNVR
Univar Solutions Inc.
UNVR
|
+$9.78M |
| 5 |
Iovance Biotherapeutics
IOVA
|
+$6.45M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cedar Fair
FUN
|
+$23.4M |
| 2 |
RPM International
RPM
|
+$19M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$10.8M |
| 4 |
Novartis
NVS
|
+$8.61M |
| 5 |
Blue Bird Corp
BLBD
|
+$8.32M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 15.64% |
| 2 | Healthcare | 14.52% |
| 3 | Industrials | 13.36% |
| 4 | Technology | 12.98% |
| 5 | Communication Services | 9.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Abbott
ABT
$179B
| $201K | 0.01% |
+2,745
| New | +$180K |
|
102
GSK
GSK
$101B
| $201K | 0.01% |
4,000
| – | – |
|
103
Altria Group
MO
$118B
| $52K | ﹤0.01% |
+868
| New | +$51.5K |
|
104
Pathward Financial
CASH
$1.64B
| – | – |
-147,630
| Closed | -$4.79M |
|
105
Collegium Pharmaceutical
COLL
$708M
| – | – |
-227,785
| Closed | -$5.43M |
|
|
106
Cedar Fair
FUN
$1.3B
| – | – |
-371,103
| Closed | -$23.4M |
|
107
Inogen
INGN
$138M
| – | – |
-14,283
| Closed | -$2.66M |
|
108
iRhythm Holdings
IRTC
$3.71B
| – | – |
-60,545
| Closed | -$4.91M |
|
109
PRA Group
PRAA
$756M
| – | – |
-88,545
| Closed | -$3.41M |
|
110
SiteOne Landscape Supply
SITE
$3.93B
| – | – |
-62,225
| Closed | -$5.22M |
|
111
Zillow
ZG
$7.35B
| – | – |
-138,438
| Closed | -$8.27M |
|
|
TECX
112
Tectonic Therapeutic
TECX
$568M
| – | – |
-6,889
| Closed | -$2.36M |
|
|
SUM
113
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| – | – |
-224,172
| Closed | -$5.79M |
|
|
TWOU
114
DELISTED
2U Inc
TWOU
| – | – |
-959
| Closed | -$2.4M |
|
|
NEWR
115
DELISTED
New Relic, Inc.
NEWR
| – | – |
-44,905
| Closed | -$4.52M |
|
|
TRHC
116
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| – | – |
-76,000
| Closed | -$4.85M |
|
Similar funds
SP
CWP
MSR
CP
PCM
MWA
GC
PSC
Osterweis Capital Management's Q3 2018 Portfolio in Review
As of Q3 2018, Osterweis Capital Management held 125 positions worth $1.57B, up 1.3% from $1.55B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Osterweis Capital Management withdrew a net $234M in Q3 2018, closing 13 positions and reducing 30 holdings. Its most notable exit was Cedar Fair, an estimated $23.4M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 16% of assets, down from 19% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Osterweis Capital Management opened a new position in 3M worth $11.6M.
- Osterweis Capital Management's largest Q3 2018 buy was 3M: 65,912 shares worth $11.6M.
- Osterweis Capital Management added most to Apple in Q3 2018, an estimated $19.1M increase.
- Osterweis Capital Management's biggest Q3 2018 reduction was RPM International, cutting an estimated $19M.
- Osterweis Capital Management fully exited Cedar Fair in Q3 2018, selling an estimated $23.4M.
- Osterweis Capital Management's ten largest holdings make up 28% of its $1.57B portfolio in Q3 2018.
- Osterweis Capital Management opened 20 new positions and closed 13 in Q3 2018.
- Osterweis Capital Management's portfolio value rose 1.3% quarter-over-quarter to $1.57B.
Based on Osterweis Capital Management's 13F filing for Q3 2018, filed 13 Nov 2018.